Atlas Trials

Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient

Clinical trial NCT04654195 · UNKNOWN

Trial details

NCT number
NCT04654195
Sponsor
Damanhour University
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast Cancer Patients
Start date
2020-12-01
Primary completion
2021-02-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.